With the hope of contributing new knowledge that could help in the development of future medications, UTSA’s researchers are trying to learn more about the qualities of an enzyme called CYP121, which ...

tuberculosis, the pathogen responsible ... "Our finding that the new compound is effective against other members of the Mycobacterium genus may also prove to be valuable in the fight against ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...